Conjunctival Papilloma Medication

Updated: Jun 14, 2019
  • Author: Hon-Vu Quang Duong, MD; Chief Editor: Hampton Roy, Sr, MD  more...
  • Print
Medication

Medication Summary

The goals of pharmacotherapy are to reduce morbidity and to prevent complications.

Next:

H2-receptor antagonists

Class Summary

Indicated for recalcitrant conjunctival papilloma.

Cimetidine (Tagamet)

May enhance immune system by inhibiting suppressor T-cell function and augmenting delayed-type hypersensitivity responses.

Previous
Next:

Immune modulators

Class Summary

May induce delayed hypersensitivity reaction causing the tumor to regress. Exact mechanism is unknown.

Dinitrochlorobenzene

Contact sensitizers that induce allergic contact dermatitis, causing a localized inflammation and immune response.

Previous
Next:

Interferon

Class Summary

Naturally produced proteins with antiviral, antitumor, and immunomodulatory actions.

Interferon alpha-2b (Intron A)

Protein product manufactured by recombinant DNA technology. Mechanism of antitumor activity is not clearly understood; however, direct antiproliferative effects against malignant cells and modulation of host immune response may play important roles.

Previous
Next:

Antineoplastic agents

Class Summary

Inhibit cell growth and proliferation.

Mitomycin-C (Mutamycin)

Acts like alkylating agent, inducing DNA cross-linking, primarily with guanine and cytosine base pairs, which, in turn, inhibits DNA synthesis.

Previous